Reduced small-intestinal injury induced by indomethacin in interleukin-17A-deficient mice

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 2, 2011, Pages 398-404

  Yamada, Shinya ^a   Naito, Yuji ^a   Takagi, Tomohisa ^a   Mizushima, Katsura ^a   Hirai, Yasuko ^a   Horie, Ryusuke ^a   Fukumoto, Kohei ^a   Inoue, Ken ^a   Harusato, Akihito ^a   Yoshida, Naohisa ^a   Uchiyama, Kazuhiko ^a   Handa, Osamu ^a   Ishikawa, Takeshi ^a   Konishi, Hideyuki ^a   Wakabayashi, Naoki ^a   Yagi, Nobuaki ^a   Kokura, Satoshi ^a   Kita, Masakazu ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Interleukin 17A; Mice; Non steroidal anti inflammatory agents

Indexed keywords

CHEMOATTRACTANT; GRANULOCYTE COLONY STIMULATING FACTOR; INDOMETACIN; INTERLEUKIN 17; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; HISTOPATHOLOGY; HOMOZYGOSITY; INTESTINE INJURY; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 78851468864     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06496.x     Document Type: Article

References (42)

1. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 1992; 327: 749-54.
2. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-47.
3. Fujimori S, Seo T, Gudis K etal. Diagnosis and treatment of obscure gastrointestinal bleeding using combined capsule endoscopy and double balloon endoscopy: 1-year follow-up study. Endoscopy 2007; 39: 1053-8.
4. Morris AJ, Madhok R, Sturrock RD, Capell HA, MacKenzie JF. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 1991; 337: 520.
5. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin. Gastroenterol. Hepatol. 2005; 3: 133-41.
6. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin. Gastroenterol. Hepatol. 2005; 3: 55-9.
7. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-8.
8. Bjarnason I, Takeuchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J. Gastroenterol 2009; 44 (Suppl. 19): 23-9.
9. Higuchi K, Umegaki E, Watanabe T etal. Present status and strategy of NSAIDs-induced small bowel injury. J. Gastroenterol. 2009; 44: 879-88.
10. Omatsu T, Naito Y, Handa O etal. Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells. J. Gastroenterol. 2009; 44 (Suppl. 19): 30-4.
11. Higuchi K, Yoda Y, Amagase K etal. Prevention of NSAID-induced small intestinal mucosal injury: prophylactic potential of lansoprazole. J. Clin. Biochem. Nutr. 2009; 45: 125-30.
12. Watanabe-Fukuda Y, Yamamoto M, Miura N etal. Orengedokuto and berberine improve indomethacin-induced small intestinal injury via adenosine. J. Gastroenterol. 2009; 44: 380-9.
13. Kuroda M, Yoshida N, Ichikawa H etal. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int. J. Mol. Med. 2006; 17: 89-93.
14. Okuda T, Yoshida N, Takagi T etal. CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis. Dig. Dis. Sci. 2008; 53: 657-63.
15. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-67.
16. Nakae S, Nambu A, Sudo K, Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003; 171: 6173-7.
17. Komiyama Y, Nakae S, Matsuki T etal. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006; 177: 566-73.
18. Yang XO, Chang SH, Park H etal. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 2008; 205: 1063-75.
19. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel. Dis. 2006; 12: 382-8.
20. Ye P, Rodriguez FH, Kanaly S etal. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 2001; 194: 519-27.
21. Nakae S, Komiyama Y, Nambu A etal. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002; 17: 375-87.
22. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am. J. Physiol. 1986; 251: G567-74.
23. Stadnyk AW, Dollard C, Issekutz TB, Issekutz AC. Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent. Gut 2002; 50: 629-35.
24. Evans SM, Whittle BJ. Role of bacteria and inducible nitric oxide synthase activity in the systemic inflammatory microvascular response provoked by indomethacin in the rat. Eur. J. Pharmacol. 2003; 461: 63-71.
25. Hatazawa R, Ohno R, Tanigami M, Tanaka A, Takeuchi K. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats. J. Pharmacol. Exp. Ther. 2006; 318: 691-9.
26. Satoh H, Shiotani S, Otsuka N, Hatao K, Nishimura S. Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats. Gut 2009; 58: 1590-6.
27. Coury F, Annels N, Rivollier A etal. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat. Med. 2008; 14: 81-7.
28. Ito R, Kita M, Shin-Ya M etal. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 2008; 377: 12-16.
29. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 2004; 110: 55-62.
30. Otani K, Watanabe T, Tanigawa T etal. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem. Biophys. Res. Commun. 2009; 382: 252-8.
31. Shiomi S, Toriie A, Imamura S etal. IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter 2008; 13: 518-24.
32. Fossiez F, Djossou O, Chomarat P etal. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 1996; 183: 2593-603.
33. Qiu Z, Dillen C, Hu J etal. Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunobiology 2009; 214: 835-42.
34. Laan M, Cui ZH, Hoshino H etal. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 1999; 162: 2347-52.
35. Lemos HP, Grespan R, Vieira SM etal. Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production. Proc. Natl. Acad. Sci. U S A. 2009; 106: 5954-9.
36. Maione F, Paschalidis N, Mascolo N, Dufton N, Perretti M, D'Acquisto F. Interleukin 17 sustains rather than induces inflammation. Biochem. Pharmacol. 2009; 77: 878-87.
37. Forlow SB, Schurr JR, Kolls JK, Bagby GJ, Schwarzenberger PO, Ley K. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 2001; 98: 3309-14.
38. Schwarzenberger P, La Russa V, Miller A etal. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 1998; 161: 6383-9.
39. Khan WI, Motomura Y, Wang H etal. Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2006; 291: G803-11.
40. Watanabe T, Higuchi K, Hamaguchi M etal. Monocyte chemotactic protein-1 regulates leukocyte recruitment during gastric ulcer recurrence induced by tumor necrosis factor-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 287: G919-28.
41. Watanabe T, Higuchi K, Kobata A etal. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57: 181-7.
42. Hata K, Andoh A, Shimada M etal. IL-17 stimulates inflammatory responses via NF-kappaB and MAP kinase pathways in human colonic myofibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 2002; 282: G1035-44.